| 2.18 0.32 (17.2%) | 11-21 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 3.09 |
1-year : | 3.61 |
| Resists | First : | 2.65 |
Second : | 3.09 |
| Pivot price | 1.81 |
|||
| Supports | First : | 1.9 |
Second : | 1.44 |
| MAs | MA(5) : | 2.04 |
MA(20) : | 1.88  |
| MA(100) : | 2.6 |
MA(250) : | 3.37 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 68 |
D(3) : | 64.8 |
| RSI | RSI(14): 54.4 |
|||
| 52-week | High : | 6.4 | Low : | 1.44 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ ISPR ] has closed below upper band by 6.1%. Bollinger Bands are 12.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.35 - 2.36 | 2.36 - 2.37 |
| Low: | 1.84 - 1.85 | 1.85 - 1.86 |
| Close: | 2.16 - 2.18 | 2.18 - 2.2 |
Ispire Technology Inc. manufactures e-cigarettes and cannabis vaping products. The company was founded in 2019 and is based in Los Angeles, California. Ispire Technology Inc.
Mon, 17 Nov 2025
Ispire Technology and IKE Tech Applaud FDA Crackdown, Call for Tech-Driven Enforcement to Prevent Illicit Trade and Protect Youth - PR Newswire
Sat, 15 Nov 2025
Ispire Technology (NASDAQ:ISPR) Stock Rating Upgraded by Zacks Research - MarketBeat
Fri, 07 Nov 2025
Ispire Technology Inc. (NASDAQ:ISPR) Q1 2026 Earnings Call Transcript - Insider Monkey
Thu, 06 Nov 2025
Ispire Technology Inc. Reports Financial Results for Fiscal First Quarter 2026 - PR Newswire
Thu, 06 Nov 2025
Ispire Technology Reports Strategic Shift and Cost Reductions - TipRanks
Thu, 06 Nov 2025
Ispire Technology Inc. (ISPR) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Tobacco
|
|
| Shares Out | 57 (M) |
| Shares Float | 20 (M) |
| Held by Insiders | 66.5 (%) |
| Held by Institutions | 8.4 (%) |
| Shares Short | 703 (K) |
| Shares Short P.Month | 596 (K) |
| EPS | -0.65 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.03 |
| Profit Margin | -31.2 % |
| Operating Margin | -8.9 % |
| Return on Assets (ttm) | -19.6 % |
| Return on Equity (ttm) | -255 % |
| Qtrly Rev. Growth | -22.8 % |
| Gross Profit (p.s.) | 0.35 |
| Sales Per Share | 2.06 |
| EBITDA (p.s.) | -0.61 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -12 (M) |
| Levered Free Cash Flow | -30 (M) |
| PE Ratio | -3.36 |
| PEG Ratio | 0 |
| Price to Book value | -72.67 |
| Price to Sales | 1.05 |
| Price to Cash Flow | -10.27 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|